CDH1 and pancreatic neoplasm: Overexpression of miR-29a resulted in an increase in epithelial marker, E-cadherin, and reduction in mesenchymal marker, Vimentin, indicating that reintroduction of miR-29a induces mesenchymal–epithelial transition (MET) in pancreatic cancer cells.